1050 related articles for article (PubMed ID: 15767107)
21. Diffusion-tensor imaging for glioma grading at 3-T magnetic resonance imaging: analysis of fractional anisotropy and mean diffusivity.
Lee HY; Na DG; Song IC; Lee DH; Seo HS; Kim JH; Chang KH
J Comput Assist Tomogr; 2008; 32(2):298-303. PubMed ID: 18379322
[TBL] [Abstract][Full Text] [Related]
22. A Magnetic Resonance comparative study between enhancement, rCBV and ACD in brain glioblastomas.
Aprile I; Muti M; Principi M; Bartolini N; Zenoni A; Tazza G; Italiani M; Ottaviano P
Radiol Med; 2002; 104(1-2):87-91. PubMed ID: 12386559
[TBL] [Abstract][Full Text] [Related]
23. [Differentiation between glioma recurrence and radiation-induced brain injuries using perfusion-weighted magnetic resonance imaging].
Wang YL; Liu MY; Wang Y; Xiao HF; Sun L; Zhang J; Ma L
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2013 Aug; 35(4):416-21. PubMed ID: 23987489
[TBL] [Abstract][Full Text] [Related]
24. Predicting the histopathological grade of cerebral gliomas using high b value MR DW imaging at 3-tesla.
Alvarez-Linera J; Benito-León J; Escribano J; Rey G
J Neuroimaging; 2008 Jul; 18(3):276-81. PubMed ID: 18482368
[TBL] [Abstract][Full Text] [Related]
25. Dynamic susceptibility contrast-enhanced perfusion magnetic resonance (MR) imaging combined with contrast-enhanced MR imaging in the follow-up of immunogene-treated glioblastoma multiforme.
Stenberg L; Englund E; Wirestam R; Siesjö P; Salford LG; Larsson EM
Acta Radiol; 2006 Oct; 47(8):852-61. PubMed ID: 17050367
[TBL] [Abstract][Full Text] [Related]
26. Contrast/Noise ratio on conventional MRI and choline/creatine ratio on proton MRI spectroscopy accurately discriminate low-grade from high-grade cerebral gliomas.
Fayed N; Morales H; Modrego PJ; Pina MA
Acad Radiol; 2006 Jun; 13(6):728-37. PubMed ID: 16679275
[TBL] [Abstract][Full Text] [Related]
27. Perfusion magnetic resonance imaging and magnetic resonance spectroscopy of cerebral gliomas showing imperceptible contrast enhancement on conventional magnetic resonance imaging.
Batra A; Tripathi RP; Singh AK
Australas Radiol; 2004 Sep; 48(3):324-32. PubMed ID: 15344981
[TBL] [Abstract][Full Text] [Related]
28. Dynamic contrast-enhanced susceptibility-weighted perfusion imaging of intracranial tumors: a study using a 3T MR scanner.
Sentürk S; Oğuz KK; Cila A
Diagn Interv Radiol; 2009 Mar; 15(1):3-12. PubMed ID: 19263367
[TBL] [Abstract][Full Text] [Related]
29. Relative percentage signal intensity recovery of perfusion metrics—an efficient tool for differentiating grades of glioma.
Smitha KA; Gupta AK; Jayasree RS
Br J Radiol; 2015 Aug; 88(1052):20140784. PubMed ID: 26110202
[TBL] [Abstract][Full Text] [Related]
30. [Possibilities of the use of MR tomography-based cerebral blood volume maps in the diagnosis of brain tumors].
Hackländer T; Hofer M; Reichenbach J; Bettag JM; Kiwit JC; Herzog H; Mödder U
Rofo; 1995 Dec; 163(6):484-9. PubMed ID: 8547618
[TBL] [Abstract][Full Text] [Related]
31. Perfusion, diffusion and spectroscopy values in newly diagnosed cerebral gliomas.
Catalaa I; Henry R; Dillon WP; Graves EE; McKnight TR; Lu Y; Vigneron DB; Nelson SJ
NMR Biomed; 2006 Jun; 19(4):463-75. PubMed ID: 16763973
[TBL] [Abstract][Full Text] [Related]
32. Intraoperative dynamic susceptibility contrast MRI (iDSC-MRI) is as reliable as preoperatively acquired perfusion mapping.
Ulmer S; Hartwigsen G; Riedel C; Jansen O; Mehdorn HM; Nabavi A
Neuroimage; 2010 Feb; 49(3):2158-62. PubMed ID: 19900562
[TBL] [Abstract][Full Text] [Related]
33. High cerebral blood volume in human gliomas predicts deletion of chromosome 1p: Preliminary results of molecular studies in gliomas with elevated perfusion.
Law M; Brodsky JE; Babb J; Rosenblum M; Miller DC; Zagzag D; Gruber ML; Johnson G
J Magn Reson Imaging; 2007 Jun; 25(6):1113-9. PubMed ID: 17520715
[TBL] [Abstract][Full Text] [Related]
34. Perfusion MR imaging in gliomas: comparison with histologic tumor grade.
Lee SJ; Kim JH; Kim YM; Lee GK; Lee EJ; Park IS; Jung JM; Kang KH; Shin T
Korean J Radiol; 2001; 2(1):1-7. PubMed ID: 11752962
[TBL] [Abstract][Full Text] [Related]
35. Tissue characterization of glioma by proton magnetic resonance spectroscopy and perfusion-weighted magnetic resonance imaging: glioma grading and histological correlation.
Toyooka M; Kimura H; Uematsu H; Kawamura Y; Takeuchi H; Itoh H
Clin Imaging; 2008; 32(4):251-8. PubMed ID: 18603178
[TBL] [Abstract][Full Text] [Related]
36. Quantitative assessment of gliomas by proton magnetic resonance spectroscopy.
Oshiro S; Tsugu H; Komatsu F; Abe H; Onishi H; Ohmura T; Iwaasa M; Sakamoto S; Fukushima T
Anticancer Res; 2007; 27(6A):3757-63. PubMed ID: 17970039
[TBL] [Abstract][Full Text] [Related]
37. Conventional MR imaging with simultaneous measurements of cerebral blood volume and vascular permeability in ganglioglioma.
Law M; Meltzer DE; Wetzel SG; Yang S; Knopp EA; Golfinos J; Johnson G
Magn Reson Imaging; 2004 Jun; 22(5):599-606. PubMed ID: 15172052
[TBL] [Abstract][Full Text] [Related]
38. Dynamic contrast-enhanced derived cerebral blood volume correlates better with leak correction than with no correction for vascular endothelial growth factor, microvascular density, and grading of astrocytoma.
Haris M; Husain N; Singh A; Husain M; Srivastava S; Srivastava C; Behari S; Rathore RK; Saksena S; Gupta RK
J Comput Assist Tomogr; 2008; 32(6):955-65. PubMed ID: 19204461
[TBL] [Abstract][Full Text] [Related]
39. High-grade gliomas and solitary metastases: differentiation by using perfusion and proton spectroscopic MR imaging.
Law M; Cha S; Knopp EA; Johnson G; Arnett J; Litt AW
Radiology; 2002 Mar; 222(3):715-21. PubMed ID: 11867790
[TBL] [Abstract][Full Text] [Related]
40. [Application of diffusion tensor imaging in preoperation and postoperation patients of glioma with 3.0 Tesla MRI].
Li X; Yu RT; Xu K; Li FC; Fan YC; Gao WC; Guo KQ; Pan X; Yang C
Zhonghua Yi Xue Za Zhi; 2009 May; 89(19):1300-4. PubMed ID: 19615179
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
